The Brest University Hospital is taking part in a global study on COPD, “the smoker’s disease”

Fifth leading cause of death in the world, COPD, also called smoker’s disease, affects around three million French people, with irreversibly obstructed bronchi. Le CHU de Brest (Finistère) is one of eight French trial centers to take part in an international study on an innovative treatment for the disease. It was launched in 2019 by … Read more